Skip to content
healthcare.dev

CNJ-016

NDC 60492-0173, Vaccinia Immune Globulin Intravenous (Human), injection, from Emergent BioSolutions Canada Inc..

Product NDC
60492-0173
Status
Listed
Labeler
Emergent BioSolutions Canada Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125109
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0173 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN VACCINIA VIRUS IMMUNE GLOBULIN1 [iU]/mL

Pharmacologic classes

Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]; Virus Neutralization [MoA]; Virus-specific Hyperimmune Globulins [EXT]

Package NDCNDC-11Package
60492-0173-26049201730224 VIAL, SINGLE-USE in 1 CARTON (60492-0173-2) / 12 mL in 1 VIAL, SINGLE-USE (60492-0173-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe

Use it

Look up 60492-0173 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0173 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60492-0173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.